Save your place

Sign in to WhoBought

Please try again later.

Akebia Therapeutics, Inc. (AKBA) institutional ownership

Latest close $1.28 Jul 20, 2026
Market cap$562M 52-week range SectorHealthcare
Funds holding · Q1 2026
154
reported AKBA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $23M
71 buyers · 83 sellers

Akebia Therapeutics, Inc. (AKBA) price and institutional activity

Dates

Q1 2026

$11M bought by 71 investors
Two Sigma Investments, LP$1.7MAQR Capital Management LLC$1.6M +69 more
$34M sold by 83 investors
Citadel Advisors LLC-$4.5MState Street-$2.8M +81 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Akebia Therapeutics, Inc. (AKBA) institutional activity · 154

Investor Type Est. change Change Δ Own Date
Citadel Advisors LLC Reduced· Q1 2026 −$4.5M −3.3M −70.2% Q1 2026
State Street · Reduced −$2.8M
Change −2.1M Date Q1 2026
State Street Reduced· Q1 2026 −$2.8M −2.1M Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −$2.4M −1.8M −49.0% Q1 2026
Federated Hermes, Inc. · Exited −$1.8M
Change −1.3M Δ Own −100.0% Date Q1 2026
Federated Hermes, Inc. Exited· Q1 2026 −$1.8M −1.3M −100.0% Q1 2026
Two Sigma Investments, LP · Added +$1.7M
Change +1.2M Δ Own +1332.2% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +$1.7M +1.2M +1332.2% Q1 2026
AQR Capital Management LLC · Added +$1.6M
Change +1.1M Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +$1.6M +1.1M Q1 2026
Goldman Sachs Group Inc · Reduced −$1.5M
Change −1.1M Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −$1.5M −1.1M Q1 2026
First Trust Advisors LP · Exited −$1.3M
Change −942K Δ Own −100.0% Date Q1 2026
First Trust Advisors LP Exited· Q1 2026 −$1.3M −942K −100.0% Q1 2026
Acadian Asset Management LLC · Reduced −$1.1M
Change −823K Date Q1 2026
Acadian Asset Management LLC Reduced· Q1 2026 −$1.1M −823K Q1 2026
Squarepoint Ops LLC · Reduced −$1.1M
Change −800K Date Q1 2026
Squarepoint Ops LLC Reduced· Q1 2026 −$1.1M −800K Q1 2026
Barclays PLC · Reduced −$1.1M
Change −781K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −$1.1M −781K Q1 2026
Jane Street Group, LLC · Added +$1.1M
Change +765K Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +$1.1M +765K Q1 2026
Vanguard · Reduced −$1.0M
Change −753K Date Q1 2026
Vanguard Reduced· Q1 2026 −$1.0M −753K Q1 2026
Nordea Investment Management AB · Exited −$1.0M
Change −752K Δ Own −100.0% Date Q1 2026
Nordea Investment Management AB Exited· Q1 2026 −$1.0M −752K −100.0% Q1 2026
Millennium Management LLC · Added +$1.0M
Change +731K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$1.0M +731K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 154

Famous investor activity in Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics, Inc. (AKBA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ostrowski Erik · Officer Sell −$62K
Price $1.11 Qty −56K Owned 617K ΔOwn −8.3% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Ostrowski Erik Officer Sell $1.11 −56K −$62K 617K −8.3% Jun 29, 2026 Jul 1, 2026
Wolf Myles · Director 2 operations 89K
Owned 54K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Wolf Myles Director 2 operations 89K 54K Jun 17, 2026 Jun 22, 2026
Smith Cynthia · Director 2 operations 89K
Owned 54K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Smith Cynthia Director 2 operations 89K 54K Jun 17, 2026 Jun 22, 2026
Rogers Michael W. · Director 2 operations 89K
Owned 54K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Rogers Michael W. Director 2 operations 89K 54K Jun 17, 2026 Jun 22, 2026
Frieson Ron · Director 2 operations 89K
Owned 54K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Frieson Ron Director 2 operations 89K 54K Jun 17, 2026 Jun 22, 2026
Zumwalt Leanne M. · Director 2 operations 89K
Owned 54K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Zumwalt Leanne M. Director 2 operations 89K 54K Jun 17, 2026 Jun 22, 2026
Adams Adrian · Director 2 operations 89K
Owned 54K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Adams Adrian Director 2 operations 89K 54K Jun 17, 2026 Jun 22, 2026
7 of 7

Akebia Therapeutics, Inc. (AKBA) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Blackrock, Inc. 15.2M
% of shares outstanding 7.2% Filing date Nov 8, 2024
Blackrock, Inc. 15.2M 7.2% Nov 8, 2024
State Street Corp 11.6M
% of shares outstanding 4.3% Filing date May 12, 2026
State Street Corp 11.6M 4.3% May 12, 2026
Satter Muneer A 5.7M
% of shares outstanding 2.6% Filing date Feb 14, 2025
Satter Muneer A 5.7M 2.6% Feb 14, 2025
BlackRock Inc. 4.3M
% of shares outstanding 2.4% Filing date Jul 8, 2022
BlackRock Inc. 4.3M 2.4% Jul 8, 2022
State Street Corp
% of shares outstanding 0.3% Filing date Jan 20, 2023
State Street Corp 0.3% Jan 20, 2023
Vanguard Group Inc 0
% of shares outstanding 0.0% Filing date Mar 26, 2026
Vanguard Group Inc 0 0.0% Mar 26, 2026
Wellington Management Group LLP 711
% of shares outstanding 0.0% Filing date Aug 10, 2021
Wellington Management Group LLP 711 0.0% Aug 10, 2021
7 of 7

Akebia Therapeutics, Inc. (AKBA) ownership FAQ

Who owns AKBA?

154 reporting institutions disclosed AKBA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.